148 related articles for article (PubMed ID: 35587053)
1. LncRNA TUG1 aggravates the progression of prostate cancer and predicts the poor prognosis.
Xu T; Liu CL; Li T; Zhang YH; Zhao YH
Eur Rev Med Pharmacol Sci; 2022 May; 26(9):3057. PubMed ID: 35587053
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA TUG1 promotes progression via upregulating DGCR8 in prostate cancer.
Yang XL; Wei C; Zhang YB; Guo HQ
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7554. PubMed ID: 32744659
[TBL] [Abstract][Full Text] [Related]
3. MiRNA-616 aggravates the progression of bladder cancer by regulating cell proliferation, migration and apoptosis through downregulating SOX7.
Zhao X; Li D; Zhao ST; Zhang Y; Xu A; Hu YY; Fang Z
Eur Rev Med Pharmacol Sci; 2022 Jun; 26(12):4158. PubMed ID: 35776012
[TBL] [Abstract][Full Text] [Related]
4. TUG1 promotes the development of prostate cancer by regulating RLIM.
Guo BH; Zhao Q; Li HY
Eur Rev Med Pharmacol Sci; 2021 Apr; 25(7):2826. PubMed ID: 33877677
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA PANDAR promotes progression and predicts poor prognosis via upregulating ROCK1 in prostate cancer.
Yang J; Zhao S; Li B
Eur Rev Med Pharmacol Sci; 2020 Nov; 24(22):11466. PubMed ID: 33275206
[TBL] [Abstract][Full Text] [Related]
6. Retraction Note: Overexpression of long non-coding RNA TUG1 alleviates TNF-α-induced inflammatory injury in interstitial cells of Cajal.
Zhao K; Tan JY; Mao QD; Ren KY; He BG; Zhang CP; Wei LZ
Eur Rev Med Pharmacol Sci; 2023 Jul; 27(13):5946. PubMed ID: 37458619
[TBL] [Abstract][Full Text] [Related]
7. Expression of lncRNA TUG1 in hypertensive patients and its relationship with change state of an illness.
Du SS; Zuo XJ; Xin Y; Man JX; Wu ZL
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):3. PubMed ID: 33506882
[TBL] [Abstract][Full Text] [Related]
8. LncRNA ZEB2-AS1 promotes the proliferation, migration and invasion of esophageal squamous cell carcinoma cell through miR-574-3p/HMGA2 axis.
Xu JH; Chen RZ; Liu LY; Li XM; Wu CP; Zhou YT; Yan JD; Zhang ZY
Eur Rev Med Pharmacol Sci; 2021 May; 25(9):3397. PubMed ID: 34002806
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA SNHG14 acts as an oncogene in prostate cancer via targeting miR-613.
Sun B; Ke KB; Liu DF; Wang Q; Li YN; Chen JH; Zhang JH
Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):10919. PubMed ID: 33215403
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA MIAT promotes the growth and metastasis of non-small cell lung cancer by upregulating TDP43.
Zhao HL; Xu SQ; Li Q; Zhao YB; Li X; Yang MP
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7209. PubMed ID: 32706047
[TBL] [Abstract][Full Text] [Related]
11. LncRNA PAPAS aggravates the progression of gastric cancer through regulating miRNA-188-5p.
Shi X; You X; Zeng WC; Deng YJ; Hong HL; Huang OX; Wang MF
Eur Rev Med Pharmacol Sci; 2021 Mar; 25(6):2462. PubMed ID: 33829425
[TBL] [Abstract][Full Text] [Related]
12. Circ_0005276 aggravates the development of epithelial ovarian cancer by targeting ADAM9.
Liu ZH; Liu WJ; Yu XY; Qi XL; Sun CC
Eur Rev Med Pharmacol Sci; 2022 Jun; 26(11):3798. PubMed ID: 35731047
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA LUCAT1 promotes migration and invasion of prostate cancer cells by inhibiting KISS1 expression.
Liu C; Wang L; Li YW; Cui YS; Wang YQ; Liu S
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7213. PubMed ID: 32706051
[TBL] [Abstract][Full Text] [Related]
14. LncRNA CASC15 promotes migration and invasion in prostate cancer via targeting miR-200a-3p.
Zhang C; Wang GX; Fu B; Zhou XC; Li Y; Li YY
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7215. PubMed ID: 32706053
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA OR3A4 promotes cisplatin resistance of non-small cell lung cancer by upregulating CDK1.
Shang J; Xu YD; Zhang YY; Li M
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):11989. PubMed ID: 33336716
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA PVT1-214 enhances gastric cancer progression by upregulating TrkC expression in competitively sponging way.
Zhao S; Fan NF; Chen XH; Zhuo CH; Xu CW; Lin RB
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(16):8245. PubMed ID: 32894523
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA LINP1 promoted proliferation and invasion of ovarian cancer via inhibiting KLF6.
Li Y; Hou CZ; Dong YL; Zhu L; Xu H
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):7918. PubMed ID: 32767311
[TBL] [Abstract][Full Text] [Related]
18. MiR-466 as a poor prognostic predictor suppresses cell proliferation and EMT in breast cancer cells by targeting PSMA7.
Xiao Y; Zhang SJ; Yan X; Wu C; Liu QW; Dong HX; Wang LJ; Hu Y
Eur Rev Med Pharmacol Sci; 2022 Jun; 26(11):3799. PubMed ID: 35731048
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA DSCAM-AS1 indicates a poor prognosis and modulates cell proliferation, migration and invasion in ovarian cancer via upregulating SOX4.
Li Y; Hao J; Jiang YM; Liu Y; Zhang SH
Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):10915. PubMed ID: 33215399
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA PCAT-1 promoted ovarian cancer cell proliferation and invasion by suppressing KLF6.
Liu HP; Lv D; Wang JY; Zhang Y; Chang JF; Liu ZT; Tang N
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7566. PubMed ID: 32744671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
